Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2014
Title: Ubaldina Galli: Innovator in Phosphatidylinositol 3-Kinase Inhibition
Introduction
Ubaldina Galli is a notable inventor from Castagneto Po, Italy, recognized for her contributions to the field of biochemistry. She has developed innovative compounds that target specific kinase activities, which are crucial in various pathological conditions. Her work exemplifies the intersection of scientific research and practical application in medicine.
Latest Patents
Ubaldina Galli holds a patent for "Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases." This patent describes compounds of Formula (I) that are capable of inhibiting kinase activity, particularly the activity of Phosphatidylinositol 3-Kinases. The compounds are also proposed for use in treating pathological conditions associated with alterations in Phosphatidylinositol 3-Kinases activity. She has 1 patent to her name.
Career Highlights
Throughout her career, Ubaldina Galli has worked with prestigious institutions, including the Università Degli Studi Di Torino and the Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro." Her research has significantly contributed to the understanding of kinase inhibitors and their therapeutic potential.
Collaborations
Ubaldina has collaborated with esteemed colleagues such as Giovanni Sorba and Gian Cesare Tron. These partnerships have enhanced her research and expanded the impact of her work in the scientific community.
Conclusion
Ubaldina Galli's innovative work in the field of phosphatidylinositol 3-kinase inhibition showcases her dedication to advancing medical science. Her contributions are vital for developing new treatments for various diseases, highlighting the importance of research and innovation in healthcare.